Increased expression of placental growth factor in high-grade endometrial carcinoma

Oncology Reports

Volumn 29, Issue 2, 2013, Pages 413-418

  Coenegrachts, Lieve ^a   Schrauwen, Stefanie ^a   Van Bree, Rita ^a   Despierre, Evelyn ^a   Luyten, Catherine ^a   Jonckx, Bart ^c   Stassen, Jean Marie ^c   Vergote, Ignace ^a,b   Amant, Frédéric ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Katholieke Universiteit   (Belgium)

^c ThromboGenics NV   (Belgium)

Author keywords

Angiogenic factor; Endometrial cancer; Placental growth factor

Indexed keywords

MESSENGER RNA; PLACENTAL GROWTH FACTOR;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CELL LYSATE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA; CASE-CONTROL STUDIES; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; PREGNANCY PROTEINS; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84872781130     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2178     Document Type: Article

References (27)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Zannoni GF, Scambia G and Gallo D: The dualistic model of endometrial cancer: the challenge of classifying grade 3 endometrioid carcinoma. Gynecol Oncol 127: 262-263, 2012.
3. Amant F, Moerman P, Neven P, Timmerman D, Van LE and Vergote I: Endometrial cancer. Lancet 366: 491-505, 2005. (Pubitemid 41111699)
4. Kamat AA, Merritt WM, Coffey D, Lin YG, Patel PR, Broaddus R, Nugent E, Han LY, Landen CN Jr, Spannuth WA, Lu C, Coleman RL, Gershenson DM and Sood AK: Clinical and biological significance of vascular endothelial growth factor in endometrial cancer. Clin Cancer Res 13: 7487-7495, 2007.
5. Rasila KK, Burger RA, Smith H, Lee FC and Verschraegen C: Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets. Int J Gynecol Cancer 15: 710-726, 2005. (Pubitemid 41783074)
6. Seki N, Kodama J, Hongo A, Miyagi Y, Yoshinouchi M and Kudo T: Vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer. Eur J Cancer 36: 68-73, 2000. (Pubitemid 30035346)
7. Stefansson IM, Salvesen HB and Akslen LA: Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res 66: 3303-3309, 2006.
8. Kerbel RS: Tumor angiogenesis. N Engl J Med 358: 2039-2049, 2008. (Pubitemid 351656458)
9. Fischer C, Mazzone M, Jonckx B and Carmeliet P: FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 8: 942-956, 2008.
10. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De MM, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, Di Palma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D and Persico MG: Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7: 575-583, 2001. (Pubitemid 32448325)
11. Fischer C, Jonckx B, Mazzone M, Zacchigna S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M, De MM, Autiero M, Wyns S, Plaisance S, Moons L, van RN, Giacca M, Stassen JM, Dewerchin M, Collen D and Carmeliet P: Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131: 463-475, 2007. (Pubitemid 350007692)
12. Coenegrachts L, Maes C, Torrekens S, Van LR, Mazzone M, Guise TA, Bouillon R, Stassen JM, Carmeliet P and Carmeliet G: Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation. Cancer Res 70: 6537-6547, 2010.
13. Van de Veire S, Stalmans I, Heindryckx F, Oura H, Tijeras-Raballand A, Schmidt T, Loges S, Albrecht I, Jonckx B, Vinckier S, Van SC, Tugues S, Rolny C, De MM, Dettori D, Hainaud P, Coenegrachts L, Contreres JO, Van BT, Cuervo H, Xiao WH, Le HC, Buysschaert I, Kharabi MB, Geerts A, Schomber T, Bonnin P, Lambert V, Haustraete J, Zacchigna S, Rakic JM, Jimenez W, Noel A, Giacca M, Colle I, Foidart JM, Tobelem G, Morales-Ruiz M, Vilar J, Maxwell P, Vinores SA, Carmeliet G, Dewerchin M, Claesson-Welsh L, Dupuy E, Van VH, Christofori G, Mazzone M, Detmar M, Collen D and Carmeliet P: Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell 141: 178-190, 2010.
14. Maae E, Olsen DA, Steffensen KD, Jakobsen EH, Brandslund I, Sorensen FB and Jakobsen A: Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer. Breast Cancer Res Treat 133: 257-265 2012.
15. Parr C, Watkins G, Boulton M, Cai J and Jiang WG: Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Eur J Cancer 41: 2819-2827, 2005. (Pubitemid 41713119)
16. Wei SC, Tsao PN, Yu SC, Shun CT, Tsai-Wu JJ, Wu CH, Su YN, Hsieh FJ and Wong JM: Placenta growth factor expression is correlated with survival of patients with colorectal cancer. Gut 54: 666-672, 2005. (Pubitemid 40559252)
17. Sivridis E, Giatromanolaki A, Anastasiadis P, Georgiou L, Gatter KC, Harris A L, Bicknell R and Koukourakis MI: A ngiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas. J Pathol 196: 416-422, 2002. (Pubitemid 34262853)
18. Pecorelli S: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105: 103-104, 2009.
19. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De KB, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ and Carmeliet P: Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8: 831-840, 2002.
20. Koukourakis MI, Limberis V, Tentes I, Kontomanolis E, Kortsaris A, Sivridis E and Giatromanolaki A: Serum VEGF levels and tissue activation of VEGFR2/KDR receptors in patients with breast and gynecologic cancer. Cytokine 53: 370-375, 2011.
21. Chang YT, Chang MC, Wei SC, Tien YW, Hsu C, Liang PC, Tsao PN, Jan IS and Wong JM: Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer. Pancreas 37: 145-150, 2008.
22. Pompeo E, Albonici L, Doldo E, Orlandi A, Manzari V, Modesti A and Mineo TC: Placenta growth factor expression has prognostic value in malignant pleural mesothelioma. Ann Thorac Surg 88: 426-431, 2009.
23. Wei SC, Liang JT, Tsao PN, Hsieh FJ, Yu SC and Wong JM: Preoperative serum placenta growth factor level is a prognostic biomarker in colorectal cancer. Dis Colon Rectum 52: 1630-1636, 2009.
24. Zhang L, Chen J, Ke Y, Mansel RE and Jiang WG: Expression of placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance. World J Surg Oncol 3: 68, 2005.
25. Chen CN, Hsieh FJ, Cheng YM, Cheng WF, Su YN, Chang KJ and Lee PH: The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. Cancer Lett 213: 73-82, 2004.
26. Voss MA, Ganesan R, Ludeman L, McCarthy K, Gornall R, Schaller G, Wei W and Sundar S: Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-A clinical and pathological evaluation. Gynecol Oncol 124: 15-20, 2012.
27. Martinsson-Niskanen T, Riisbro R, Larsson L, Winstedt L, Stenberg Y, Pakola S, Stassen JM and Glazer S: Monoclonal antibody TB-403: a first-in-human, Phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects. Clin Ther 33: 1142-1149, 2011.